Urokinase receptor antagonists: Novel agents for the treatment of cancer

Expert Opinion on Investigational Drugs

Volumn 7, Issue 3, 1998, Pages 391-403

  Weidle, U H ^a   Konig, B ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Amino terminal fragment of urokinase; Anti invasive therapy; Extracellular matrix; Growth factor domain of urokinase; Minimal Residual Disease; Receptor antagonists; Urokinase; Urokinase receptor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; RECEPTOR BLOCKING AGENT; UROKINASE; UROKINASE RECEPTOR;

CANCER; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG TARGETING; GENE EXPRESSION; GENE THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; MINIMAL RESIDUAL DISEASE; NONHUMAN; RECEPTOR BINDING; REVIEW; SURVIVAL TIME;

EID: 0031950693     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.3.391     Document Type: Review

References (71)